* In vitro 체외진단 / IVD 시장 2021년 전망 - 제품별 (인스트루먼츠, 시약, 소프트웨어), 기술 (면역 분석, 임상 화학, 분자 진단, 혈액학), 어플리케이션 (당뇨병, 종양학, 심장학, 신장학, 전염병)
In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - Forecast to 2021
The global in vitro diagnostics market is valued at USD 60.22 Billion in 2016. This market is expected to grow at a CAGR of 5.5% during the forecast period (2016–2021) to reach USD 78.74 Billion by 2021. The growing acceptance of molecular diagnostics in personalized medicine, increasing prevalence of lifestyle and chronic diseases, growth in the number of private diagnostic centers are key factors driving market growth. Untapped emerging regions showcase new growth opportunities for this market. However, market growth is restrained by the lack of reimbursement and increasing healthcare cost.
This research study involved the extensive usage of both primary and secondary data sources as well as various factors affecting the industry, including the regulatory landscape; competitive scenario; historic data; current trends in the market; technological innovations and upcoming technologies; and market drivers, restraints, opportunities, and challenges.
In this report, the in vitro diagnostics market is segmented by products & services, technology, application, end user, and region. Based on application, the market is segmented into diabetes, infectious diseases, oncology/cancer, cardiology, HIV/AIDS, autoimmune diseases, nephrology, drug testing/pharmacogenomics, and others. The infectious diseases segment accounted for the largest share of the market in 2015, owing to the rising incidence of infectious disorder such as rise in the incidence of tuberculosis (TB), hepatitis, and hospital-acquired infections.
Geographically, North America dominated the global in vitro diagnostics market in 2015. The large share of this region can be attributed to presence of developed healthcare systems in the U.S. & Canada, increasing acceptance of personalized medicine, and growing adoption of technologically advanced products in this region. The Asia-Pacific region is expected to register the highest CAGR, due to the growth in research activities and increasing investments by leading players and respective government agencies in the region.
The key players in this market are Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Siemens Healthineers (Germany), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Sysmex Corporation (Japan), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux (France), and Becton, Dickinson and Company (U.S.), Johnson and Johnson (U.S.), Qiagen N.V. (Germany), Ortho-Clinical Diagnostics, Inc. (U.S.), and Diasorin S.P.A. (Italy).
•IVD Product Manufacturers
•Group Purchase Organizations (GPOs)
•Original Equipment Manufacturers (OEM)
•Pathologists and Pathology Laboratories
•Distributors of IVD Products
•Hospitals and Clinics
•Market Research and Consulting Firms
To know about the assumptions considered for the study, download the pdf brochure
Scope of the Report
This research report categorizes the global in vitro diagnostics market into the following segments:
Global In Vitro Diagnostics Market, by Products and Services
•Reagents & Kits
•Data Management Software
Global In Vitro Diagnostics Market, by Technology
•Clinical Chemistry◦Basic Metabolic Panel
◦Thyroid Function Panel
◦Specialty Chemical Tests
•Immunochemistry/Immunoassay◦Enzyme-Linked Immunosorbent Assay (ELISA)◾Chemiluminescence Immunoassay (CLIA)
◾Fluorescence Immunoassay (FIA)
◾Colorimetric Immunoassay (CI)
•Coagulation & Hemostasis
•Molecular Diagnostics (MDx)◦Polymerase Chain Reaction (PCR)
◦Isothermal Nucleic Acid Amplification Technology (INAAT)
◦DNA Sequencing & Next-generation Sequencing
◦Other MDx technologies
Global In Vitro Diagnostics Market, by Application
Global In Vitro Diagnostics Market, by End User
•Other End Users
Global In Vitro Diagnostics Market, by Region
◦Rest of Europe (RoE)
◦Rest of Asia-Pacific (RoAPAC)
◦Rest of Latin America (RoLA)
•Middle East and Africa
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
•Product matrix, which gives a detailed comparison of the product portfolios of each company
•Further breakdown of the Rest of Asia-Pacific in vitro diagnostics market in South Korea, Australia, New Zealand, and other countries
•Detailed analysis and profiling of additional market players (Up to 5)
The global in vitro diagnostics market is estimated to reach USD 78.74 Billion by 2021, at a CAGR of 5.5% during the forecast period. The growing acceptance of molecular diagnostics for personalized medicine, increase in prevalence of chronic lifestyle diseases, and rise in demand for point-of-care testing are driving market growth. New range of condition-specific markers and tests with advances in genomics & proteomics and growth in emerging markets due to increasing investments presents significant growth opportunities for players in the market. However, the rising healthcare costs & lower budgets and inadequate reimbursement are the major restraining factors for this market.
In this report, the market is segmented on the basis of products & services, technology, application, end user, and region. The research report discusses key market drivers, restraints, opportunities, and challenges in the global in vitro diagnostics market and its submarkets. Based on products & services, the market is segmented into reagents & kits, instruments, services, and data management software. The reagents & kits segment accounted for the largest share of the market in 2015; it is expected to grow at the highest CAGR during the forecast period. Accessibility to a wide range of reagents and the need for reliable, specific, and faster detection of chronic diseases and genetic disorders at early stages are expected to drive the growth of this segment.
Based on end user, in vitro diagnostics market is segmented into hospitals, laboratories, academic institutes, POC (point-of-care) testing, patient self-testing, and others. The hospitals segment accounted for the largest share of the global market in 2015. The large share of this segment can be attributed to the large number of diagnostic tests carried out in hospitals.
In this report, the global market has been studied at the regional and country levels. In 2015, North America represented the largest regional market, followed by Europe. While North America will continue to dominate the market during the forecast period, the Asia-Pacific region is expected to register the highest growth. The growth of this regional segment is driven by the improving healthcare infrastructure, significant economic development in emerging markets, and rising focus of key market players on this region.
In Vitro Diagnostics/IVD Market
The major players in the global in vitro diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Siemens Healthineers (Germany), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Sysmex Corporation (Japan), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux (France), and Becton, Dickinson and Company (U.S.), Johnson and Johnson (U.S.), Qiagen N.V. (Germany), Ortho-Clinical Diagnostics, Inc. (U.S.), and Diasorin S.P.A. (Italy).